General Information of Drug (ID: DMAPV1B)

Drug Name
Glatiramer Acetate Drug Info
Synonyms
Glatiramer acetate; Copaxone; 147245-92-9; Copolymer 1; Copolymer-1; COP-1; Protiramer; Glatopa; L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt); L-alanine compound with L-glutamic acid and L-lysine and L-tyrosine and acetic acid (1:1:1:1:1); (2S)-2,6-diaminohexanoic acid; TV 5010; UNII-5M691HL4BO; Glatirameracetat; Glatiramer acetate [USAN:BAN]; AC1MIXQC; 5M691HL4BO
Indication
Disease Entry ICD 11 Status REF
Multiple sclerosis 8A40 Approved [1]
Therapeutic Class
Immunosuppressive Agents
Cross-matching ID
PubChem CID
3081884
CAS Number
CAS 147245-92-9
TTD Drug ID
DMAPV1B
ACDINA Drug ID
D01127

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MHC class II antigen DRB1*1 (HLA-DRB1) TTLCMWF 2B11_HUMAN Binder [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1058).
2 Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14593-8.